Interaction of PTH and PTHrP with Their Receptors

被引:40
作者
Gardella T.J. [1 ]
Jüppner H. [1 ,2 ]
机构
[1] Endocrine Unit, Department of Medicine, Harvard Medical School, Boston, MA
[2] Pediat. Massachusetts Gen. Hospital, Harvard Medical School, Boston, MA
关键词
G protein-coupled receptor; Parathyroid hormone; Parathyroid hormone-related peptide; Peptide hormone family; Photochemical crosslinking; Receptor binding; Receptor mutagenesis; Signal transduction; Structure-activity relationship;
D O I
10.1023/A:1026522619828
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:317 / 329
页数:12
相关论文
共 83 条
[1]  
Kronenberg H.M., Bringhurst F.R., Nussbaum S., Juppner H., Abou-Samra A.B., Segre G.V., Potts J.T. Jr., Parathyroid hormone: Biosynthesis, secretion, chemistry and action, Handbook of Experimental Pharmacology: Physiology and Pharmacology of Bone, pp. 185-201, (1993)
[2]  
Potts J.T. Jr., Juppner H., Parathyroid hormone and parathyroid hormone-related peptide in calcium homeostasis, bone metabolism and bone development: The proteins, their genes and receptors, Metabolic Bone Disease, pp. 51-94, (1997)
[3]  
Brown E.M., Gamba G., Riccardi D., Lombardi M., Butters R., Kifor O., Sun A., Hediger M.A., Lytton J., Hebert S.C., Cloning and characterization of an extracellular Ca<sup>2+</sup>-sensing receptor from bovine parathyroid, Nature, 366, pp. 575-580, (1993)
[4]  
Broadus A.E., Stewart A.F., Parathyroid hormone-related protein: Structure, processions and physiological action, The Parathyroids. Basic and Clinical Concepts, pp. 259-294, (1994)
[5]  
Karaplis A.C., Luz A., Glowacki J., Bronson R., Tybulewicz V., Kronenberg H.M., Mulligan R.C., Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene, Genes Develop, 8, pp. 277-289, (1994)
[6]  
Lanske B., Karaplis A.C., Luz A., Vortkamp A., Pirro A., Karperien M., Defize L.H.K., Ho C., Mulligan R.C., Abou-Samra A.B., Juppner H., Segre G.V., Kronenberg H.M., PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth, Science, 273, pp. 663-666, (1996)
[7]  
Kemp B.E., Mosely J.M., Rodda C.P., Ebeling P.R., Wettenhall R.E.H., Stapleton D., Diefenbach-Jagger H., Ure F., Michelangali V.P., Simmons H.A., Raisz L.G., Martin T.J., Parathyroid hormone-related protein of malignancy: Active synthetic fragments, Science, 238, pp. 1568-1570, (1987)
[8]  
Tregear G.W., Van Rietschoten J., Greene E., Keutmann H.T., Niall H.D., Reit B., Parsons J.A., Potts J.T. Jr., Bovine parathyroid hormone: Minimum chain length of synthetic peptide required for biological activity, Endocrinology, 93, pp. 1349-1353, (1973)
[9]  
Horiuchi N., Holick M.F., Potts J.T. Jr., Rosenblatt M., A parathyroid hormone inhibitor in vivo: Design and biologic evaluation of a hormone analog, Science, 220, pp. 1053-1055, (1983)
[10]  
Nutt R.F., Caulfield M.P., Levy J.J., Gibbons S.W., Rosenblatt M., McKee R.L., Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7-34)NH<sub>2</sub> by substitution of PTH amino acids at positions 10 and 11, Endocrinology, 127, pp. 491-493, (1990)